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Objectives: Cardiopulmonary bypass is associated with extensive thrombin 
generation and cell activation. Our main hypothesis in this study was that 
the expression of tissue factor on circulating monocytes contributes to the 
formation of thrombin. Methods: Markers of activation of the coagulation 
cascade and cell activation were measured in 26 patients undergoing 
elective heart operations randomized to the use of heparin-coated (Duraflo 
II, n = 13) or standard cardiopulmonary b pass circuits (n = 13). Results: 
Thrombin generation, measured as the thrombin-antithrombin complex, 
increased considerably during cardiopulmonary b pass with peak levels 3 
hours afterward and with remaining elevation 20 hours later. Despite 
increased monocyte and granulocyte activation and increased levels of 
monocyte chemotactic protein-1 , which upregulates monocyte tissue factor 
expression in vitro, monocyte tissue factor expression was not increased at
the end of cardiopulmonary b pass. Furthermore, at this time the mono- 
cytes were less sensitive to in vitro stimulation by endotoxin. These results 
might be explained by simultaneous enhanced levels of interleukin-10, 
which effectively downregulates monocyte tissue factor expression in vitro. 
Twenty hours after cardiopulmonary b pass was discontinued, the tissue 
factor expression on freshly isolated monocytes and on monocytes timu- 
lated by endotoxin was significantly increased compared with preoperative 
levels. At this time increased activation markers of granulocytes, mono- 
cytes, and lymphocytes were also recorded. None of the measured param- 
eters was found to be different between the groups. Conclusions: The tissue 
factor expression on circulating monocytes is upregulated the day after 
heart operations. The clinical relevance and the regulatory mechanism 
behind the enhanced expression , however, are not fully elucidated. 
(J Thorac Cardiovasc Surg 1997;113:576-84) 
D uring heart operations with cardiopulmonary bypass (CPB), thrombin generation is extensive 
and therefore heparin is administered at high con- 
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centrations.1, 2 In addition, CPB induces strong ac- 
tivation of different leukocytes)' 4 It has been spec- 
ulated that the contact of the blood with the 
extracorporeal circuit, via the intrinsic coagulation 
pathway, is the main contributor to the increased 
thrombin generation. 5 Elevated levels of activated 
coagulation factor XI I  (factor XIIa) during CPB 
support his theory? It is, however, doubtful that the 
co tact activation is the main source of the throm- 
bin generation. First, Boisclair and coworkers 7 have 
published ata that suggest hat the main trigger of 
the coagulation is provided via the tissue factor (TF) 
pathway as a result of factor VI Ia  bonded to TF. 
The TF/factor VI Ia complex then activates the 
coagulation cascade through the activation of fac- 
tors IX and X. Second, levels of thrombin were 
formed in a patient with severe factor XI I  deficiency 
that were comparable to levels in patients with 
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Table I. Clinical characteristics and intraoperative 
and postoperative data of the patient groups 
Group HC Group C 
Gender (No. of patients) 
Male 8 11 
Female 5 2 
Age (yr) 69 +_ 6.8 72 + 6.5 
Operation type (No. of patients) 
AVR + CABG 8 11 
AVR 3 2 
MVR + CABG 2 0 
CPB time (min) 152 _+ 30 139 _+ 29 
Aortic crossclamping (rain) 92 _+ 17 89 _+ 19 
Time of ventilator support (hr) 14.4 + 19.5 9.9 _+ 4.7 
Blood loss on day 1 (ml) 934 _+ 347 792 _+ 520 
Retransfused drained blood (ml) 752 -- 395 665 _+ 413 
No significant differences existed between the two groups. The data are 
presented as mean plus or minus the standard eviation. AVR, aortic valve 
replacement; CABG, coronary artery bypass grafting; MVR, mitral valve 
replacement. 
normal factor XI I  undergoing cardiac operation, s 
Thus factor XI I  activation is not always indispens- 
able for thrombin generation during heart opera- 
tions. Extracorporeal circuits coated with heparin 
are generally believed to be more biocompatible 
than uncoated surfaces, because they reduce contact 
activation of the coagulation cascade and have fewer 
cell-activating properties. 9 However, most authors 
report no reduction in thrombin generation in pa- 
tients operated on with use of this type of device 
whereas others have found evidence of some possi- 
ble benefit of these surfaces on the coagulation 
cascade)' 10-12 
In this work, we focused on the circulating mono- 
cytes as a source of TF. Normally there is no TF or 
only trace amounts of TF in contact with the blood. 
Monocytes are, however, able to express TF on 
activation by different stimuli, including endotoxin, 
immune complexes, tumor necrosis factor, interleu- 
kin-l/3 (IL-1/3), and monocyte chemotactic pro- 
tein-1 (MCP-1)J  3' 14 Moreover, the induction of TF 
is highly dependent on cellular interactions between 
different leukocytes and plateletsJ 5'16 It has also 
been shown that the activation of the monocytes 
through the adhesion molecule CDl lb  increases TF 
expression, t7 In contrast o these inducing agents, 
IL-4, IL-10, and IL-13 are cytokines with the po- 
tency to inhibit the generation of TF at the gene 
level. ~s 
Recently, Kappelmayer and associates I9 showed 
that simulated extracorporeal circulation induces 
the expression of TF on circulating monocytes. Our 
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Fig. 1. The concentration of TAT levels before, during, 
and after CPB. TAT levels increased uring CPB with 
maximum levels being reached 3 hours after the conclu- 
sion of CPB. On the first postoperative morning, the TAT 
levels had decreased but were still significantly elevated 
compared with preoperative alues. Data are expressed as 
medians and 25% to 75% ranges. ***p < 0.001 in 
comparison with preoperative l vels. 
main hypothesis was that monocyte TF is, at least 
partly, the cause of the enhanced thrombin genera- 
tion during CPB. Therefore we measured the TF 
expression on the surface of freshly isolated mono- 
cytes. To investigate whether the monocytes were 
primed during CPB, we also stimulated the mono- 
cytes in vitro with endotoxin. The possible effect of 
cellular interactions between monocytes, lympho- 
cytes, and granulocytes on the TF expression was 
also evaluated. To test the hypothesis that heparin- 
coated surfaces have a beneficial effect on coagula- 
tion and cell activation, we randomly allocated the 
patients to operations with either heparin-coated 
(Bentley Duraflo II system) or conventional, un- 
coated surfaces. 
Patients and methods 
Patients. The study groups comprised 26 patients 
scheduled for cardiac procedures that were expected to be 
longer than standard procedures. The patients were ran- 
domized to receive CPB with use of either heparin-coated 
oxygenator, tubing, connectors, and blood cardioplegia 
sets (group HC) (Duraflo II, Baxter) or an uncoated but 
otherwise identical circuit (group C) (Univox, Baxter). In 
both groups the patients received standard heparin, that 
is, 300 IU/kg body weight, and CPB was started when the 
activated clotting time was longer than 480 seconds. 
Additional heparin doses were given if the activated 
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Fig. 2. TF levels before and after CPB (a) on freshly isolated monocytes and (b) after 4 hours of 
stimulation with 0.1 /xg/ml of lipopolysaccharide (LPS). TF levels on fresh monocytes were elevated 20 
hours after the end of CPB. At this time all patients had monocytes expressing TF. At the end of CPB, the 
monocytes expressed less TF after lipopolysaccharide stimulation compared with the preoperative l vels. 
The cells were more sensitive to the stimulus the day after the operation. Data are presented as medians 
and 25% to 75% ranges. *p = 0.02; **p = 0.003; ***p < 0.001 in comparison with preoperative l vels. 
clotting time fell to less than 480 seconds. After the 
patients were weaned from CPB, protamine was given for 
heparin reversal. The study protocol was approved by the 
Ethical Committee of the Medical Faculty. Informed 
consent was obtained from all patients. 
Anesthesia. Morphine and scopolamine were used for 
premedication and anesthesia was induced with thiopen- 
tone and fentanyl. Muscle relaxation was achieved with 
pancuronium. The lungs were ventilated with 50% N20 in 
oxygen until shortly before CPB was started, when nitrous 
oxide administration was discontinued. Ventilation after 
CPB was with oxygen in air. Fentanyl and isoflurane were 
used to maintain anesthesia. 
CBP. The CPB technique was the same in both groups. 
A St6ckert heart-lung machine (St6ckert Instrumente, 
Munich, Germany) was used. After the aorta was cross- 
clamped, an initial dose of cold blood cardioplegic solu- 
tion (10 ° to 12 ° C) was administered in an antegrade 
fashion and antegrade or retrograde administration was 
repeated when needed. Moderate body hypothermia (28 ° 
to 30 ° C) was used and the blood flow was nonpulsatile 
starting at 2.2 L/min per square meter of body surface 
area and then decreased by 25% at 30 ° C. Patients were 
rewarmed to 36 ° C (rectal) before weaning from bypass. 
Drained blood was retransfused from the end of the 
operation until 16 hours after operation. 
Blood samples and measurements. Arterial blood was 
sampled after induction of anesthesia, fter 60 minutes of 
CPB, at the end of CPB, and at 3 hours and 20 hours after 
the discontinuation f CPB. Samples for activated clotting 
time were taken whenever indicated. Blood samples dur- 
ing CPB were drawn from the arterial ine of the heart- 
lung machine and at the other times from a catheter in the 
radial artery. After centrifugation, the plasma was imme- 
diately frozen and stored at -70 ° C until analysis. 
Plasma levels of thrombin-antithrombin complex 
(TAT) and cytokines were quantified by sandwich en- 
zyme-linked immunosorbent assay techniques (Enzygnost 
TAT test, Behringwerke, Marburg, Germany, and Quan- 
tikine IL-10, soluble IL-2Ra, and MCP-1 tests, R & D 
Systems, Abingdon, United Kingdom). The activated clot- 
ting time was assessed with the Hattersly technique with 
use of a Hemochron model 400 analyzer (International 
Technidyne, Edison, N.J.) and coagulation test tubes 
(celite diatomaceous earth activated, CA 510). Erythro- 
cyte volume fraction and leukocyte count, including cell 
differentiation, were determined with an automatic ell 
counter (Coulter, Hialeah, Fla.). The results were not 
corrected for hemodilution. 
Endotoxin determination. All chemicals used for the 
induction of tissue factor were checked with a sensitive 
chromogenic Limulus amebocyte lysate assay as previ- 
ously described. 14'2° Only chemicals negative to endo- 
toxin (<5 pg/ml) were used for in vitro incubation of 
monocytes. 
Preparation of leukocytes. For analysis of CD l lb  on 
monocytes and granulocytes and of human leukocyte 
antigen-DR on CD4 + T lymphocytes, leukocytes were 
isolated by the use of ammonium chloride lysis of eryth- 
rocytes, as originally described by Hamblin and col- 
leagues 21 and modified by us: arterial blood was sampled 
in heparin tubes (Terumo Venoject, Leuven, Belgium) 
after induction of anesthesia, t the end of CPB, and 20 
hours after CPB. The blood was mixed with equal 
amounts of 0.4% paraformaldehyde in a phosphate-buff- 
ered saline buffer and incubated at 37 ° C for 3 minutes. A
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Fig. 3. Levels before and after CPB of the adhesion molecule CD11b on (a) monocytes and (b) 
granulocytes as measured by flow cytometry analysis. CD l lb  levels increased during CPB on both 
monocytes and granulocytes. In the monocytes, the levels remained unchanged 20 hours after CPB whereas 
CDl lb  levels decreased in the granulocytes. The data are shown as medians and 25% to 75% ranges. *p = 
0.04; **p = 0.002; ***p < 0.001 in comparison with preoperative l vels. 
20-fold excess of 0.83% ammonium chloride lysing buffer 
in 0.01 mol/L Tris was added followed by 15 minutes of 
incubation at 37 ° C. The cells were washed twice in 
phosphate-buffered saline solution and placed on ice. 
Mononuclear cell separation and induction of TF ex- 
pression. Arterial blood samples were taken into heparin 
tubes (Terumo Venoject) after induction of anesthesia, t
the end of CPB, and 20 hours after discontinuation of
CPB. For the analysis of TF, mononuclear cells were 
isolated by gradient centrifugation with the use of Ficoll- 
Paque gradient. 14 The cell suspension obtained by this 
procedure contained 20% to 35% monocytes, 60% to 80% 
tymphocytes, and 0% to 5% granulocytes before opera- 
tion; 10% to 30% monocytes, 70% to 90% lymphocytes, 
and 0% to 10% granulocytes at the end of CPB; and 30% 
to 60% monocytes, 30% to 60% lymphocytes, and 0% to 
10% granulocytes the morning after the operation. Cells 
for the analysis of TF on freshly isolated monocytes were 
immediately stained with antibodies and analyzed by flow 
cytometry. 
To study whether the monocytes were primed in vivo, 
the cells were first stimulated in vitro (37 ° C, 5% CO2) for 
4 hours by 0.1 b~g/ml of lipopolysaccharide (Sigma, St. 
Louis, Mo.) as previously described. 14
Flow cytometry analysis. Analyses of cell surface struc- 
tures were done in samples from 20 of the 26 patients (10 
group C and 10 group HC). The cells were stained as 
14 previously described with one or two of the following 
monoclonal antibodies: anti-tissue factor..(TF9-9C3, Cor- 
vas, San Diego, Calif.), anti-CD14 vlTc (TUK4, Dakopatts, 
PE Glostrup, Denmark), CD4 (MT310, Dakopatts),human 
F ITC leukocyte antigen-DR (CR3/43, Dakopatts), and 
CDl lb  PE (Leu-15, Becton Dickinson, San Jose, Calif.). 
Irrelevant antibodies of appropriate immunoglobulin G
subclasses, concentrations, and fluorochrome (Dakopatts) 
were used as negative controls. The TF-stained cells were 
further stained with a fluorescein isothiocyanate-labeled 
F(ab')2 fraction of a rabbit anti-mouse immunoglobulin 
(Dakopatts). The stained cells were fixed in 1% parafor- 
maldehyde buffer and kept on ice until analysis was done 
with an EPICS Profile II flow cytometer (Coulter). Gating 
of the cells was done with side and forward light scatter 
properties in combination with anti-CD14 (monocytes) or 
anti-CD4 (T helper/inducer lymphocytes) stained cells. 
The mean fluorescence intensity units (MFI) and the 
percentage of positive cells were determined for each 
sample. 
Statistical analysis. The Statistica for Windows pro- 
gram (StatSoft, Tulsa, Okla.) was used for all statistical 
analyses. The results are presented as medians and twen- 
ty-fifth to seventy-fifth percentile ranges. The Friedman 
analysis of variance test was used for analyses of time 
series within each group. When significant differences 
were obtained, these were further evaluated by the Wil- 
coxon matched pairs test for comparison between two 
samples within the series. The Mann-Whitney U test was 
used for intergroup comparisons. Prevalences were eval- 
uated by Fisher's exact est and correlation analyses were 
done with the Spearman rank order correlation. Ap  value 
of less than 0.05 was considered to be statistically signifi- 
cant. 
Results 
There were no significant intergroup differences 
in clinical parameters  or b lood loss (Table I). The 
postoperat ive course was uneventful  for all pat ients 
except one who needed pro longed venti latory sup- 
port  because of respiratory insufficiency. 
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Fig. 4. a, Soluble IL-2Rc~ (sIL-2Rc 0 in plasma nd b, human leukocyte antigen-DR (HLA-DR) on CD4 ÷ 
T cells before and after CPB. At the end of CPB, soluble IL-2Rc~ levels decreased as a result of 
hemodilution. After the termination of CPB, the levels increased and elevated levels of the cytokine were 
observed 20 hours later. At this time, an elevation was also observed in the human leukocyte antigen-DR 
levels on CD4-- T cells. Data shown as median values and 25% to 75% ranges. *p = 0.03; ***p < 0.001 
in comparison with preoperative levels. 
For all measured parameters, tatistical analyses 
were done for both groups with either heparin- 
coated CPB or standard surfaces. However, between 
the two groups no significant difference was ob- 
served for any of the measured parameters. There- 
fore the data are presented as one set. 
Cell counts. A modest decrease in the total leu- 
kocyte count (p = 0.03), neutrophil count (not 
significant), and monocyte count (p < 0.0001) was 
observed uring the first hour of CPB. During the 
later phase of CPB, an increase in the total leuko- 
cyte count was observed, which was attributed to an 
increase in the neutrophil count, whereas the mono- 
cyte and lymphocyte counts decreased. A further 
increase in the neutrophil count was observed 20 
hours after the end of CPB. At this time, the 
monocyte count was also elevated. The relation 
between lymphocytes and monocytes decreased 
from more than 3:1 before operation to less than 1:1 
on the first postoperative morning. 
Coagulation activity. The TAT levels gradually 
increased during CPB with an almost 20-fold in- 
crease at the end of CPB (Fig. 1). Three hours later, 
the TAT concentrations had further increased. By 
the first postoperative morning the levels had de- 
creased, but compared with baseline levels a fivefold 
enhancement was still observed (p < 0.0001). 
Before operation, 2.2% (0% to 5.2%) of freshly 
isolated monocytes expressed TF (Fig. 2, a). At the 
end of CPB there was no increase in the TF levels 
(2.4% [0% to 12.8%]). However, at this time, a 
monocyte TF expression of 10% or more was found in 
5 of the 20 patients, as compared with only 2 patients 
before the operation. A significant (p = 0.02) increase 
in the TF levels was recorded 20 hours after CPB with 
4.6% (2.2% to 12.0%) of the monocytes expressing TF 
and with more than 10% of the monocytes positive for 
TF in five of the patients. No patient had 0% TF- 
expressing monocytes the day after the operation, as 
compared with six patients before operation and five at 
the end of CPB. 
To evaluate the capacity of the monocytes to 
express TF on their surface, we incubated the mono- 
nuclear cells with 0.1 /xg/ml of lipopolysaccharide 
for 4 hours. The TF-inducing capacity, as measured 
by the number of TF receptors per cell (MFI), by 
lipopolysaccharide stimulation, was decreased at the 
end of CPB (p = 0.003) (Fig. 2, b). However, the 
number of TF-positive cells was not significantly 
changed compared with preoperative l vels. In con- 
trast, the sensitivity to lipopolysaccharide stimula- 
tion was significantly enhanced 20 hours after the 
end of CPB with an increase in both the MFI and 
the number of TF-positive monocytes (p = 0.001). 
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Fig. 5. Generation of (a) MCP-1 and (b) IL-10 before and after CPB. The MCP-1 levels increased during 
heart operation with CPB, reaching maximum levels 3 hours after termination ofCPB. The levels declined 
the day after the operation, but were still elevated. The IL-10 levels increased extensively during CPB, 
reaching peak levels at the end of CPB. The IL-10 levels then rapidly declined, although elevated levels 
were still noticed 20 hours after the end of CPB. Note the large differences between patients with some 
having very high levels of MCP-1 or IL-10. Data are presented as median values and 25% to 75% ranges. 
**p = 0.003; ***p < 0.001 in comparison with preoperative l vels. 
CDl lb levels on monocytes and granulocytes. To 
evaluate the possible cause of the enhanced mono- 
cyte TF levels, the expression of the adhesion mol- 
ecule CDl lb  on the monocytes and the granulocytes 
was analyzed by flow cytometry. A prominent in- 
crease (p = 0.0003) in both monocyte and granulo- 
cyte cell surface expression of CDl lb  was recorded 
at the end of CPB (Fig. 3). The CDl lb  expression 
on the monocytes remained unchanged until the 
first postoperative morning. The expression of 
CDl lb  on the granulocytes peaked at the end of 
CPB and, compared with preoperative values, the 
expression was still elevated 20 hours after CPB 
(p = 0.04). 
Markers of lymphocyte activation. Lymphocytes 
are known to enhance the expression of TF on 
monocytes, 15 so with the purpose of investigating 
the activation of the lymphocytes, oluble IL-2Ro~ 
levels were measured. The plasma levels of this 
receptor decreased significantly (p < 0.0001) during 
CPB (Fig. 4, a). However, this reduction was caused 
by hemodiludon (data not shown). At the end of the 
investigation period, on the first postoperative 
morning, soluble IL-2Ro~ levels exhibited an almost 
twofold increase compared with preoperative l vels 
(p < 0.0001), indicating lymphocyte activation. 
T helper/inducer cells are the most essential lym- 
phocytes involved in the generation of monocyte 
TF. 22 Soluble IL-2Rc~ is secreted by all types of 
lymphocytes. Therefore the expression o f  human 
leukocyte antigen-DR on the surface of CD4 ÷ T 
helper/inducer cells was also analyzed. The levels of 
this surface bound molecule did not change during 
CPB (Fig. 4, b). However, a similar pattern of 
expression of human leukocyte antigen-DR on 
CD4- T helper/inducer cells and release of soluble 
IL-2Rc~ was recorded with increased levels the first 
postoperative morning (p = 0.02). 
Levels of MCP-1 and IL-10. The chemokine 
MCP-1 is released from a variety of cells, including 
activated monocytes. MCP-1 is a main activator of 
monocytes and because we have previously shown 
that it is also an efficient inducer of TF in human 
monocytes, 14the plasma levels of this chemokine 
were measured. The levels of MCP-1 increased 
significantly (i9 < 0.0001) during and shortly after 
CPB with peak values occurring 3 hours after CPB 
(Fig. 5, a). At this time, the levels had increased 
more than threefold compared with values before 
operation. The levels were still elevated 20 hours 
after the discontinuation of CPB (p = 0.003). 
At the end of CPB, the monocytes were less 
sensitive to endotoxin stimulation. These results 
might be explained by priming of the cells by yet 
unknown factors during the operative procedure. To 
test this hypothesis, the plasma levels of IL-10 were 
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Table II. Comparison of levels of coagulation markers, adhesion molecules on leukocytes, and cytokines in 
patients who underwent CPB with uncoated (group C) or heparin-coated (group HC) circuits 
Group Preop. 60 Min CPB CPB end 3 Hr after CPB 20 Hr after CPB 
TAT 0xg/L) C 3.3 (2.8-6.8) 23 (15-25) 58 (40-88) 206 (86-382) 15 (10-21) 
HC 3.3 (2.6-3.6) 23 (10-25) 64 (33-95) 201 (60-402) 18 (11-20) 
TF on fresh monocytes C 0.45 (0.0-4.6) 2.4 (0.0-10) 4.3 (2.0-9.4) 
(% positive cells) HC 2.5 (0.0-4.6) 2.0 (0.0-4.1) 4.8 (1.7-9.6) 
TF after 4 hr of LPS C 17 (14-19) 12 (7.0-13) 20 (15-27) 
stimulation (MFI) HC 16 (7-19) 11 (4.4-9.5) 20 (13-23) 
CDllb on monocytes C 5.4 (4.3-7.4) 9.8 (8.0-33) 13 (5.0-18) 
(MFI) HC 6.8 (4.3-7.6) 12 (12-20) 16 (10-19) 
CD11b on granulocytes C 4.3 (4.0-11) 12 (8.4-17) 9.1 (2.5-12) 
(MFI) HC 5.2 (3.9-6.7) 13 (8.9-15) 7.6 (6.0-10) 
Soluble IL-2Rc~ (pg/ml) C 850 (650-1200) 600 (420-750) 980 (650-1100) 1600 (1200-2100) 
HC 1000 (720-1200) 580 (420-840) 1000 (650-1300) 1900 (1500-2500) 
HLA-DR on CD4 + T cells C 15 (11-22) 17 (13-23) 18 (13-22) 
(% positive cells) HC 16 (9.8-20) 17 (12-27) 21 (14-36) 
MCP-1 (pg/ml) C 130 (92-140) 270 (210-300) 370 (290-660) 170 (98-190) 
HC 130 (92-170) 310 (250-520) 440 (280-660) 160 (120-180) 
IL-10 (pg/ml) C 7.8 (7.8-7.8) 125 (59-320) 22 (14-30) 15 (7.8-18) 
HC 7.8 (7.8-7.8) 165 (54-360) 23 (7.8-32) 7.8 (7.8-12) 
EVF C 35 (33-37) 23 (21-26) 22 (19-23.5) 28.5 (27.5-29.5) 29 (27-30.5) 
HC 32.5 (29.5-36.5) 23.5 (19.5-25.0) 21.5 (21.0-24.0) 29 (26-30) 29 (27-30) 
No significant differences xisted between the two groups. The data are presented as medians and 25% to 75% percentiIes (in parentheses). LPS, 
Lipopolysaccharide; HIM-DR, human leukocyte antigen-DR; EVF, erythrocyte volume fraction. 
measured. Before CPB, IL-10 levels were less than 
the lower detection limit of the assay in all patients 
(<7.8 pg/ml). The levels increased more than 20 
times during CPB followed by a rapid decrease after 
CPB termination (Fig. 5, b). On the first postoper- 
ative day, the IL-10 levels were still slightly elevated 
(p = 0.0003) with levels greater than the lower 
detection limit of the assay in 15 (58%) of the 26 
patients. 
Correlations. The decrease in TF-inducing ca- 
pacity by lipopolysaccharide at the end of CPB 
compared with before operation was significantly 
correlated with the IL-10 levels at the end of CPB: 
R = 0.48, p = 0.04. There was no other correlation 
between TF expression and levels of cytokines or 
adhesion molecules. 
Effect of the heparin-coated evice. No signifi- 
cant difference was observed between the two 
groups for any of the measured parameters (Table 
II). 
Discussion 
The data in this report do not support he hypoth- 
esis that TF expression on circulating monocytes i
the main cause of the enhanced coagulation activa- 
tion seen at the end of CPB. There was no statisti- 
cally significant elevation of monocyte surface ex- 
pression of TF at this time. Furthermore, the 
monocytes generated less TF when stimulated with 
endotoxin in vitro as compared with preoperative 
TF generation, which probably is a reflection of in 
vivo priming of the monocytes by yet unknown 
factors. However, as indicated in this study, IL-10 is 
likely to be one of these candidates. IL-10 is a 
powerful monocyte deactivating factor with the abil- 
ity to inhibit cytokine release. This cytokine is also a 
potent inhibitor of lipopolysaccharide- and, as we 
recently have demonstrated, MCP-l-induced TF 
expression i  human monocytes, i  Our data indicate 
that an early release of IL-10 could be of great 
importance in regulating the monocyte TF expres- 
sion in vivo. 
Although we could not detect any increased TF 
expression at the end of CPB on monocytes circu- 
lating in the blood, it was recently shown by two 
other groups that TF expression is increased in 
monocytes adherent o the surface of the CPB 
circuit, which indicates an important role of the 
monocytes in inducing thrombin formationY' 24 In 
accordance with these observations, our results 
could reflect that the most active and functional 
monocytes were adherent to the surface of the CPB 
circuit. Moreover, Chung and colleagues 23reported 
that monocytes in the pericardial blood have signif- 
icantly increased TF expression. Thus monocytes 
trapped in the area of operation, in the lungs, in the 
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myocardium, or in all these places may also express 
TF. Another possibl e source of coagulation activa- 
tion is TF expressed in the subendothelium and in 
atherosclerotic plaques, which can be exposed to the 
blood in the damaged tissue of the area of opera- 
tion.25, 26 
The coagulation activation could also depend on 
contact activation through the foreign surfaces of 
the CPB equipment. 5' 6 Coating of the surfaces of 
the CPB circuit with heparin is an attempt to 
increase the biocompatibi!ity of these surfaces. 9 In 
this study we used a heparin-coated CPB circuit 
(Duraflo II), including a heparin-coated cardiotomy 
reservoir. The thrombin generation was not de- 
creased by the use of such a device, which is in 
agreement with findings of three previous studies 
that used another heparin-coating principle (Car- 
meda Bio-Active Surface). 2'm. 11 Thus the circuit 
may still be thrombogenic despite the use of hepa- 
rin-coated internal surfaces. Alternatively, the main 
source of activation of the coagulation cascade may 
be provided by some mechanism other than the 
surface. 23 
The retransfusion of blood from the pericardial 
cavity by use of a cardiotomy reservoir is highly 
important in inducing thrombin generation. 23' 27, 28 
We have observed that operation with use of a 
cardiotomy reservoir induces higher TAT levels 
compared with operation with use of a cell salvage 
device (manuscript in preparation). Monocyte TF 
expression and thrombin generation are high in the 
pericardial blood. 23 Similarly, the extremely high 
level of TAT 3 hours after the termination of CPB, 
which is in contrast with findings of our previous 
study, 2 is probably a result of the retransfusion f 
shed mediastinal blood. 
In this study we show for the first time that he 
levels of TF on circulating monocytes are elevated 
20 hours after CPB arrest. This upregulation of TF 
may, at least partly, explain the remaining thrombin 
generation. Additionally, we also found that the 
monocytes are hyperactive in generating TF expres- 
sion on activation with endotoxin. It is highly possi- 
ble that the cells were primed in vivo by signaling 
agonists, such as cytokines. 
One of these cytokine candidates is MCP-1, a 
potent inducer of TF expression on monocytes. 14
We show that MCP-1 is released during heart 
operations with CPB and reaches very high levels 3 
hours after CPB. Furthermore, the morning after 
operation the levels are still significantly increased. 
Thus it is possible that MCP-1 is involved in the 
monocyte TF generation during and after CPB. It is 
questionable, however, whether this cytokine is the 
main cause of the TF generation. Although other 
authors have shown no or only modest increases of 
IL-1/3 and tumor necrosis factor during CPB, these 
cytokines are additional candidates. 29' 30
The enhanced activity of T helper/inducer cells, 
granulocytes, or monocytes, or all of these, on the 
first postoperative morning can ~also explain the 
enhanced TF generation because these cells are 
known to have stimulatory effects on the generation 
of TF in the monocytes. 15' 22 However, no statisti- 
cally significant correlation between the markers of 
cell activation and TF expression was Observed. This 
result might be because of the relatively small 
number of patients in the study. Lymphocytes are 
required to optimize the in vitro induction of mono- 
cyte TF expression and the optimal lymphocyte/ 
monocyte ratio is 4:1 or more. 15 Desp!te a low 
lymphocyte/monocyte ratio (1:1) 20 hours after 
CPB, we observed an increased sensitivity toward 
endotoxin, which indicated that the cells were 
primed by strong TF-inducing factors. 
In conclusion, at the end of CPB the generation of 
thrombin occurred without a simultaneous elevation 
of TF expression on circulating monocytes. In con- 
trast, TF expression on circulating monocytes was 
enhanced 20 hours after CPB. This TF expression 
may, at least partly, explain the enhanced coagula- 
tion activation. The interaction between activated 
lymphocytes, granulocytes, and monocytes or ago- 
nists released late in the bypass period may result in 
stimulation of the monocytes to express TF. How- 
ever, the regulatory mechanism and the clinical 
relevance of this monocyte TF expression are today 
not fully elucidated. 
We thank Eva Th6rn6, Elisabeth Ahlvin, Gunilla Liss, 
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